Summarized by Masters of Longevity from Tech.eu.
1nhaler secured £2.2 million to ready a single‑dose cardboard DPI for trials.
Key Takeaways
- Funding is led by Archangels with public investor support.
- Investment was used to ready clinical trial material and transfer manufacturing.
- A small clinical trial is planned to support a 2027 regulatory filing.
